CHRIS CURTIS, London School of Hygiene and Tropical Medicine The current method of distributing insecticidal nets for malaria isn’t working well enough. Chris Curtis explains what needs to be done.
REFERENCE: ABSTRACT N Engl J Med 2007; 357: 28-381 STUART POCOCK, London School of Hygiene and Tropical Medicine Reassuring findings about the safety of the anti-diabetic drug rosiglitazone have been published in the New England Journal of
Hodgkin’s Disease: 10-Year Results Show Further Benefit From Escalated BEACOPP Therapy
REFERENCE: Abstract 8015, ASCO Annual Meeting Chicago June 1-5, 2007 VOLKER DIEHL, University of Cologne GEORGE CANELLOS, Dana-Farber Cancer Institute, Boston Long-term results presented at
REFERENCE: ABSTRACT Lancet 2007;369:1083-89 Editorial page 1061 RUPERT PEARSE, Barts and The London School of Medicine A big step forwards in the management of patients in the emergency room who need artificial ventilation has been reported in the
REFERENCE: ABSTRACT Oral 278, also: N Engl J Med 2007;357:9-17 SJOERD REPPING, University of Amsterdam Genetic screening of embryos before implantation for in-vitro fertilisation caused a big reduction in the number of live births as compared with no
Eggs From Young Patients Before Chemotherapy: New Hope for Future Fertility
REFERENCE: ABSTRACT Oral 107, ESHRE Annual Meeting Lyon July 1-4, 2007 ARIEL REVEL, Hadassah University Hospital, Jerusalem Harvesting eggs from young girls before they undergo aggressive chemotherapy
REFERENCE: ABSTRACT Oral 005, ESHRE Annual Meeting Lyon July 1-4, 2007 PER-OLOF KARLSTRÖM, Academic Hospital Uppsala COMMENT: RICHARD KENNEDY, University Hospital, Coventry Elective single embryo transfer, now the norm in Sweden for in-vitro fertilisation, has greatly
MARTIN MCKEE, London School of Hygiene and Tropical Medicine Martin McKee on the smoking ban – and how the tobacco industry is now looking to promote oral tobacco. Is it an effort to
More Support for Bevacizumab in Advanced Lung Cancer
REFERENCE: Abstract LBA7514, ASCO Annual Meeting Chicago June 1-5, 2007 CHRISTIAN MANEGOLD, Heidelberg University, Mannheim COMMENT: ROY HERBST, MD Anderson Cancer Center, Houston The benefit of adding bevacizumab
